Document is current

Article History

Accepted: 11 July 2024

First Online: 19 August 2024

Competing interests

: P.P.-R. has received honoraria as a consultant and speaker from AbbVie, Biohaven, Chiesi, Eli Lilly, Lundbeck, Medscape, Novartis, Pfizer and Teva Pharmaceuticals. Her research group has received research grants from AbbVie, AGAUR, EraNet Neuron, FEDER RIS3CAT, Instituto Investigación Carlos III, MICINN, Novartis, and Teva Pharmaceuticals and has received funding for clinical trials from AbbVie, Biohaven, Eli Lilly, Lundbeck, Novartis and Teva Pharmaceuticals. She is the Honorary Secretary of the International Headache Society, is on the editorial board of Revista de Neurologia, is an associate editor for Cephalalgia, Headache, Neurologia, and Frontiers of Neurology, and is an adviser of the Scientific Committee of the Editorial Board of The Journal of Headache and Pain. She is a member of the Clinical Trials Guidelines Committee and Scientific Committee of the International Headache Society. She has edited the Guidelines for the Diagnosis and Treatment of Headache of the Spanish Neurological Society. She is the founder of . A.A. has received honoraria as a speaker from AbbVie, Novartis, Eli Lilly and Teva Pharmaceuticals. S.D.S. provides consultation to Alder, AbbVie, Amgen, Autonomic Technologies, Avanir, Curelater, Depomed, Dr. Reddy’s Laboratories, Ensured, ElectroCore Medical, eNeura Therapeutics, INSYS Therapeutics, Lilly USA, Pfizer, Supernus Pharmaceuticals, Teva Pharmaceuticals, Theranica and Trigemina. R.B. is the John Hedley-Whyte Professor of Anaesthesia and Neuroscience at the Beth Israel Deaconess Medical Center and Harvard Medical School. He has received research support from Allergan, Dr. Reddy, Eli Lilly, the Migraine Research Foundation, the National Institutes of Health (R01 NS094198-01A1, R37 NS079678, R01NS095655, R01 NS104296, R21 NS106345), Teva Pharmaceuticals and Trigemina. He is a reviewer for the National Institute of Neurological Disorders and Stroke; holds stock options in AllayLampand Percept; serves as a consultant, advisory board member or has received honoraria from Alder, Allergan, Amgen, Autonomic Technologies, Avanir, Biohaven, CGRP Diagnostic, Dr. Reddy’s Laboratory, ElectroCore, Eli Lilly, GlaxoSmithKline, Merck, Pernix, Theranica, Teva Pharmaceuticals and Trigemina; has received CME fees from Healthlogix, Medlogix, and WebMD/Medscape; and is named on patents 9061025, 11732265.1, 10806890, US2021-0015908, WO21007165, US2021-0128724 and WO21005497.